test

Robert Grundstein

@Sabby Management, Llc

Latest period2024 - Q3ReportedManaged Assets$186.418MTotal holdings42
Assets growth rate-99.87%Assets growth rate (2-Q avg)-57.03%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sabby Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 42 positions.

Assets under management

The assets under management (AUM) of Sabby Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 186.418M in assets, with a quarterly growth rate of -99.87% and a 2-quarter average growth rate of -57.03%. The portfolio is managed by Robert Grundstein, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
7846⤦Spdr S&p 500 Etf Tr
Recent Activity
Increased 13.99%
38.39%
$71.548M↓ Put
1,247 shares@ $57376.0 avg price
7846⤦Spdr S&p 500 Etf Tr
Recent Activity
Increased 146.39%
23.06%
$42.975M↑ Call
749 shares@ $57376.0 avg price
4642⤦Ishares Tr
Recent Activity
Increased 55.79%
5.43%
$10.117M↑ Call
458 shares@ $22089.0 avg price
2187⤦Core Scientific Inc
Recent Activity
Increased 27.17%
4.78%
$8.91M↓ Put
7,513 shares@ $1186.0 avg price
VANIVivani Medical Inc
Recent Activity
Increased 0.09%
1.34%
$2.49M
2.128M shares@ $1.17 avg price
G114⤦Bit Digital Inc
Recent Activity
Increased 44.94%
1.18%
$2.192M↓ Put
6,244 shares@ $351.0 avg price
2941⤦Eos Energy Enterprises Inc
Recent Activity
Increased 531.51%
0.52%
$958,419↓ Put
3,227 shares@ $297.0 avg price
ENSCEnsysce Biosciences Inc
Recent Activity
Increased 269.84%
0.15%
$279,022
1.163M shares@ $0.24 avg price
ATXIAvenue Therapeutics Inc
Recent Activity
Increased 68.64%
0.09%
$157,019
63,060 shares@ $2.49 avg price
6294⤦Nrx Pharmaceuticals Inc
Recent Activity
Increased 44.91%
0.07%
$129,792↓ Put
768 shares@ $169.0 avg price